Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Skrahina (Minsk region, Belarus). New and repurposed TB drugs use in children and adolescents with M/XDR-TB. 4853

Member's Comments

No comment yet.

Related content which might interest you: New and repurposed drugs for MDR-TB patients Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence  Year: 2017 New approaches to MDR/XDR TB chemotherapy in children and adolescents Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges Source: Eur Respir J 2016; 48: 938-943 Year: 2016 Effectiveness of treatment for MDR TB in children and adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Active tuberculosis case-finding among drug users and homeless persons: after the outbreak Source: Eur Respir J 2016; 48: 269-271 Year: 2016 Management of drug resistant pulmonary TB. New problems and perspectives Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006 New guidelines to manage MDR-TB Source: School Course 13 Year: 2013 Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 New anti-tuberculosis drugs for special populations: a difficult-to-address issue Source: Eur Respir J 2016; 48: 957-958 Year: 2016 Rational use of new TB drugs in the EU Source: Annual Congress 2012 - New guidelines in respiratory infections Year: 2012 New anti-tuberculosis drugs and regimens: 2015 update Source: ERJ Open Res 2015; 1: 00010-2015 Year: 2015 New perspectives in MDR-TB management Source: International Congress 2016 – China Session II Year: 2016 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Challenges in TB treatment in adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014